Liang Zhang

Title: Innovations of Liang Zhang in Pharmaceutical Chemistry

Introduction

Liang Zhang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of azabicyclo derivatives. His work focuses on the preparation and medical applications of these compounds, which have potential therapeutic uses.

Latest Patents

Liang Zhang holds a patent for "Azabicyclo derivatives, process for preparation thereof and medical use thereof." This patent describes azabicyclo derivatives of formula (I), along with their pharmaceutically acceptable salts, stereoisomers, solvates, and prodrugs. These derivatives are particularly useful as Epidermal Growth Factor Receptor (EGFR) inhibitors, which are important in cancer treatment. The patent provides detailed definitions of the variable R groups in the azabicyclo derivatives, enhancing the understanding of their chemical properties and potential applications.

Career Highlights

Throughout his career, Liang Zhang has worked with prominent companies in the pharmaceutical industry. He has been associated with Shanghai Haiyan Pharmaceutical Technology Co., Ltd. and Yangtze River Pharmaceutical Group Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Liang Zhang has collaborated with several professionals in his field, including Yunzhou Jin and Ping Bu. These collaborations have likely enriched his research and development efforts, leading to advancements in pharmaceutical applications.

Conclusion

Liang Zhang's contributions to the field of pharmaceutical chemistry, particularly through his patent on azabicyclo derivatives, highlight his innovative spirit and dedication to medical advancements. His work continues to influence the development of new therapeutic agents.